文献速递中药与中成药合理使用中医内科

绿路易波士提取物与大鼠阿托伐他汀及二甲双胍的药代动力学相互作用

Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats.
PubMed 文献 · Front Pharmacol · 2019-10-23

本研究在Wistar大鼠中评估口服富含aspalathin的绿路易波士提取物(GRT)对阿托伐他汀和二甲双胍药代动力学的影响。结果显示,GRT与阿托伐他汀联用使阿托伐他汀的Cmax和AUC0-8分别增加5.8倍(p=0.03)和5.9倍(p=0.02),而对二甲双胍血浆水平无影响。GRT可能通过增加阿托伐他汀暴露量引发草药-药物相互作用。

要点

  • GRT与阿托伐他汀联用显著增加阿托伐他汀的Cmax和AUC0-8。
  • GRT对二甲双胍的血浆水平无显著影响。
  • GRT上调Abcc2表达,二甲双胍下调Abcb1a表达。

核心结论

  • 在大鼠中,GRT与阿托伐他汀联用可导致阿托伐他汀血浆浓度升高,增加阿托伐他汀暴露量。
  • GRT对二甲双胍的药代动力学无显著影响。

研究设计与样本

  • 研究为Wistar大鼠体内药代动力学实验,GRT(50 mg/kg BW)、阿托伐他汀(40 mg/kg BW)或二甲双胍(150 mg/kg BW)单用或GRT与阿托伐他汀或二甲双胍联用。
  • 采用LC-MS/MS分析血浆样本,用PKSolver 2.0软件计算非房室和两房室药代动力学参数。
  • 用实时PCR测定Abcc2、Slco1b2、Abcb1a和Oct1 mRNA表达,分别以β-actin和HPRT归一化。

主要发现

  • GRT与阿托伐他汀联用使阿托伐他汀的Cmax增加5.8倍(p=0.03),AUC0-8增加5.9倍(p=0.02)。
  • GRT对二甲双胍的血浆水平无影响。
  • GRT增加Abcc2表达,二甲双胍下调Abcb1a表达;GRT与阿托伐他汀或二甲双胍联用未显著改变Slco1b2或Oct1的表达。

临床怎么用

  • 使用GRT或富含aspalathin的绿路易波士提取物时,需警惕与阿托伐他汀联用可能增加阿托伐他汀暴露量及相关不良反应风险。
  • GRT与二甲双胍联用可能无需调整二甲双胍剂量,但需进一步临床验证。

局限性

  • 研究仅在大鼠中进行,结果能否外推至人类尚需临床研究验证。
  • 未报告GRT对阿托伐他汀代谢酶或转运体的直接蛋白水平影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

An aspalathin-rich green rooibos extract (Afriplex GRT™) has demonstrated anti-diabetic and hypolipidemic properties, while also moderately inhibiting CYP3A4 activity, suggesting a potential for herb-drug interaction. The present study, therefore, evaluated the effects of orally administered GRT on the pharmacokinetics of atorvastatin and metformin in Wistar rats. Wistar rats were orally treated with GRT (50 mg/kg BW), atorvastatin (40 mg/kg BW) or metformin (150 mg/kg BW) alone or 50 mg/kg BW GRT in combination with 40 mg/kg BW atorvastatin or 150 mg/kg BW metformin. Blood samples were collected at 0, 10, and 30 min and 1, 2, 4, 6, and 8 h and plasma samples obtained for Liquid chromatography-mass spectrometry (LC-MS/MS) analyses. Non-compartment and two-compartment pharmacokinetic parameters of atorvastatin and metformin in the presence or absence of GRT were determined by PKSolver version 2.0 software. Membrane transporter proteins, ATP-binding cassette sub-family C member 2 (Abcc2), solute carrier organic anion transporter family, member 1b2 (Slco1b2), ATP-binding cassette, sub-family B (MDR/TAP), member 1A (Abcb1a), and organic cation transporter 1 (Oct1) mRNA expression were determined using real-time PCR expression data normalized to β-actin and hypoxanthine-guanine phosphoribosyltransferase (HPRT), respectively. Co-administration of GRT with atorvastatin substantially increased the maximum plasma concentration (Cmax) and area of the plasma concentration-time curve (AUC0-8) of atorvastatin by 5.8-fold (p = 0.03) and 5.9-fold (p = 0.02), respectively. GRT had no effect on the plasma levels of metformin. GRT increased Abcc2 expression and metformin downregulated Abcb1a expression while the combination of GRT with atorvastatin or metformin did not significantly alter the expression of Slco1b1 or Oct1 did not significantly alter the expression of Sclo1b2 or Oct1. Co-administration of GRT with atorvastatin in rats may lead to higher plasma concentrations and, therefore, to an increase of the exposure to atorvastatin.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Patel O, Muller CJF, Joubert E, et al. Pharmacokinetic Interaction of Green Rooibos Extract With Atorvastatin and Metformin in Rats. Front Pharmacol. 2019. PMID: 31708777. doi:10.3389/fphar.2019.01243

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。